115 related articles for article (PubMed ID: 33630201)
1. Effect of Activin A on activation status of monocytes in acute-phase Kawasaki disease.
Wu Q; Yang Z; Huang Y; Wang L; Weng R; Yang J
Clin Exp Med; 2021 Aug; 21(3):407-414. PubMed ID: 33630201
[TBL] [Abstract][Full Text] [Related]
2. Activin a suppresses peripheral CD8
Wu Q; Weng R; Xu Y; Wang L; Huang Y; Yang J
BMC Immunol; 2021 Feb; 22(1):17. PubMed ID: 33622252
[TBL] [Abstract][Full Text] [Related]
3. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of miR-27a promotes monocyte-mediated inflammatory responses in Kawasaki disease by inhibiting function of B10 cells.
Luo Y; Yang J; Zhang C; Jin Y; Pan H; Liu L; Gong Y; Xia Y; Wang G; Zhang J; Li C; Li Q
J Leukoc Biol; 2020 Jan; 107(1):133-144. PubMed ID: 31583766
[TBL] [Abstract][Full Text] [Related]
5. Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma.
Kariyawasam HH; Pegorier S; Barkans J; Xanthou G; Aizen M; Ying S; Kay AB; Lloyd CM; Robinson DS
J Allergy Clin Immunol; 2009 Sep; 124(3):454-62. PubMed ID: 19733294
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
7. Platelet-rich plasma-induced feedback inhibition of activin A/follistatin signaling: A mechanism for tumor-low risk skin rejuvenation in irradiated rats.
Omar NN; Rashed RR; El-Hazek RM; El-Sabbagh WA; Rashed ER; El-Ghazaly MA
J Photochem Photobiol B; 2018 Mar; 180():17-24. PubMed ID: 29413698
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of activin A on the activation of mouse macrophage RAW264.7 cells.
Ge J; Wang Y; Feng Y; Liu H; Cui X; Chen F; Tai G; Liu Z
Cell Mol Immunol; 2009 Apr; 6(2):129-33. PubMed ID: 19403063
[TBL] [Abstract][Full Text] [Related]
9. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
Gray PC; Harrison CA; Vale W
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
[TBL] [Abstract][Full Text] [Related]
10. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
[TBL] [Abstract][Full Text] [Related]
11. Increased Interleukin-35 suppresses peripheral CD14
Xing H; Tian G
BMC Immunol; 2020 Apr; 21(1):17. PubMed ID: 32276581
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth.
Tamminen JA; Yin M; Rönty M; Sutinen E; Pasternack A; Ritvos O; Myllärniemi M; Koli K
Exp Cell Res; 2015 Mar; 332(1):102-15. PubMed ID: 25557874
[TBL] [Abstract][Full Text] [Related]
13. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
Vänttinen T; Liu J; Kuulasmaa T; Kivinen P; Voutilainen R
J Endocrinol; 2003 Sep; 178(3):479-89. PubMed ID: 12967339
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta Inhibition Attenuates Vasculitis in a Mouse Model of Kawasaki Disease.
Hashimoto Y; Fukazawa R; Nagi-Miura N; Ohno N; Suzuki N; Katsube Y; Kamisago M; Akao M; Watanabe M; Hashimoto K; Tsuno K; Matsui R; Itoh Y
J Nippon Med Sch; 2019; 86(2):108-116. PubMed ID: 31130561
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
Liu X; Nagarajan RP; Vale W; Chen Y
FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
[TBL] [Abstract][Full Text] [Related]
16. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
Renlund N; O'Neill FH; Zhang L; Sidis Y; Teixeira J
J Endocrinol; 2007 Oct; 195(1):95-103. PubMed ID: 17911401
[TBL] [Abstract][Full Text] [Related]
17. Activin receptor signaling: a potential therapeutic target for osteoporosis.
Lotinun S; Pearsall RS; Horne WC; Baron R
Curr Mol Pharmacol; 2012 Jun; 5(2):195-204. PubMed ID: 21787285
[TBL] [Abstract][Full Text] [Related]
18. The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors.
Yamakawa N; Tsuchida K; Sugino H
EMBO J; 2002 Apr; 21(7):1684-94. PubMed ID: 11927552
[TBL] [Abstract][Full Text] [Related]
19. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
20. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
